Previous to 60 Minutes’, January 1, 2023, broadcast which featured correspondent Lesley Stahl’s story on weight problems, we reached out to Novo Nordisk, the maker of Wegovy and Ozempic about current shortages of the medicines.
The corporate advised 60 Minutes the next:
Ozempic
The 1 mg and a couple of mg doses of Ozempic at the moment are out there for sufferers throughout the U.S. We’re presently experiencing intermittent provide disruptions on the Ozempic pen that delivers 0.25 mg and 0.5 mg doses because of the mixture of unbelievable demand coupled with general world provide constraints. Whereas product continues to be manufactured and shipped, sufferers in some areas of the nation will expertise delays with these doses. Anybody involved with continuity of remedy, ought to contact their healthcare supplier.
Wegovy
“Novo Nordisk is happy to report that each one dose strengths of Wegovy at the moment are out there to retail pharmacies nationwide. Nonetheless, pharmacies might expertise regular delays given the time required to order the product from their native distribution middle, and geographical variabilities. Wegovy represents a big innovation within the remedy of weight problems. Whereas manufacturing is ongoing, the general demand for this drugs continues to be unsure and can proceed to be assessed. Holding provide steady is a precedence. We are going to intently monitor prescribing traits and section promotional efforts as we assess demand. We take our accountability to satisfy the wants of individuals residing with weight problems very significantly and have taken vital measures to attenuate disruption transferring ahead. We stay dedicated to driving significant change for folks residing with extra weight or weight problems and supporting healthcare suppliers partnering on their care.”
You’ll be able to watch Lesley Stahl’s full report within the video above.
Thanks for studying CBS NEWS.
Create your free account or log in
for extra options.
